Regeneron Pharmaceuticals, Inc.REGNNASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank21
5Y CAGR-49.3%
Year-over-Year Change
Year-over-year revenue growth rate
5Y CAGR
-49.3%/yr
Long-term compound
Percentile
P21
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 0.99% |
| 2024 | 8.27% |
| 2023 | 7.76% |
| 2022 | -24.26% |
| 2021 | 89.14% |
| 2020 | 29.58% |
| 2019 | -2.28% |
| 2018 | 14.28% |
| 2017 | 20.82% |
| 2016 | 18.44% |